abstract |
The invention relates to the use of an endothelin blocker in combination with an integrin receptor antagonist? 3 for the treatment or prevention of diseases, in particular the use of a pharmaceutical composition containing an endothelin blocker and a receptor antagonist for integrin? v? 3, for the treatment or prevention of cardiovascular disorders, in particular for the treatment or prevention of restenosis after vessel injury or revascularization treatment, and to the pharmaceutical composition itself. |